Skip to content

Clinical trials

Adenocarcinoma of Lung trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: Israel Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20121
20131
20142
20151
20161
20171
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Amgen1
AstraZeneca1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
Gustave Roussy, Cancer Campus, Grand Paris1
Meir Medical Center1
NRG Oncology1
Sheba Medical Center1
Spectrum Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung13
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms8
Adenocarcinoma, Bronchiolo-Alveolar2
Triple Negative Breast Neoplasms2
Adenocarcinoma1
Breast Neoplasms1
Carcinoma, Ductal1
Carcinoma, Ovarian Epithelial1
Cholangiocarcinoma1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.